NCT/Study#
NCT04551885 /
FT516-102
A Phase I, Open-Label, Multicenter Study Of FT516 In Combination With Monoclonal Antibodies In Subjects With Advanced Solid Tumors
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
